We are live on ! Find out more
NPSP

NPS PHARMACEUTICALS INC
NPSP

Delisted

NPSP was delisted on the 20th of February, 2015.

Back to rankings

213 hedge funds and large institutions have $3.63B invested in NPS PHARMACEUTICALS INC in 2014 Q4 according to their latest regulatory filings, with 45 funds opening new positions, 68 increasing their positions, 83 reducing their positions, and 28 closing their positions.

New
Increased
Maintained
Reduced
Closed

61% more first-time investments, than exits

New positions opened: 45 | Existing positions closed: 28

60% more call options, than puts

Call options by funds: $104M | Put options by funds: $64.9M

39% more capital invested

Capital invested by funds: $2.61B → $3.63B (+$1.02B)

7% more funds holding

Funds holding: 200 → 213 (+13)

0% more funds holding in top 10

Funds holding in top 10: 2 → 2 (0)

18% less repeat investments, than reductions

Existing positions increased: 68 | Existing positions reduced: 83

Holders
213
Holders Change
+13
Holders Change %
+6.5%
% of All Funds
5.68%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.05%
New
45
Increased
68
Reduced
83
Closed
28
Calls
$104M
Puts
$64.9M
Net Calls
+$38.7M
Net Calls Change
+$41.2M

Top Buyers

Rank Fund Capital Flow
1
First Trust Advisors
First Trust Advisors
Illinois
+$70.9M
2
Goldman Sachs
Goldman Sachs
New York
+$25.4M
3
FCE
Fiera Capital (Europe)
Cayman Islands
+$12.6M
4
TCM
Tekla Capital Management
Massachusetts
+$11.6M
5
Lord, Abbett & Co
Lord, Abbett & Co
New Jersey
+$11.2M

Top Sellers

Rank Fund Capital Flow
1
Wells Fargo
Wells Fargo
California
-$29.9M
2
Millennium Management
Millennium Management
New York
-$19.3M
3
AllianceBernstein
AllianceBernstein
Tennessee
-$17.9M
4
VAM
Visium Asset Management
New York
-$17M
5
PAI
Palo Alto Investors
California
-$15.2M
Name Holding Trade Value Shares
Change 		Change in
Stake
SIA
201
Stancorp Investment Advisers
Oregon
$13K +$11.1K +373 New
PNC Financial Services Group
202
PNC Financial Services Group
Pennsylvania
$12K -$287K -9,628 -97%
BFEC
203
Benjamin F. Edwards & Company
Missouri
$11K +$8.96K +300 New
TDC
204
Thompson Davis & Co
Virginia
$10K +$8.27K +277 New
Northwestern Mutual Wealth Management
205
Northwestern Mutual Wealth Management
Wisconsin
$10K +$8.33K +279 New
TRCT
206
Tower Research Capital (TRC)
New York
$8K -$90.3K -3,024 -93%
Fifth Third Bancorp
207
Fifth Third Bancorp
Ohio
$7K -$135K -4,533 -96%
FCE
208
Fiera Capital (Europe)
Cayman Islands
$3.25K +$12.6M +422,904 +12,639%
Manulife (Manufacturers Life Insurance)
209
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$2.41K -$3.6M -120,743 -64%
SEI Investments
210
SEI Investments
Pennsylvania
$2K +$2.39K +80 New
SM
211
Sabby Management
Florida
$1.49K +$814K +27,262 +189%
NG
212
NatWest Group
United Kingdom
$797 +$665K +22,281 New
BRWA
213
B. Riley Wealth Advisors
Florida
$14 +$11.9K +400 New
VAM
214
Visium Asset Management
New York
– -$17M -652,376 Closed
ARTA
215
A.R.T. Advisors
New York
– -$3.16M -121,403 Closed
LCM
216
LionEye Capital Management
New York
– -$2.99M -115,000 Closed
Balyasny Asset Management
217
Balyasny Asset Management
Illinois
– -$2.51M -84,236 Closed
DCP
218
DSM Capital Partners
Florida
– -$2.02M -77,815 Closed
Jane Street
219
Jane Street
New York
– -$1.5M -57,628 Closed
CIP
220
Convergence Investment Partners
Florida
– -$1.35M -51,900 Closed
Citadel Advisors
221
Citadel Advisors
Florida
– -$1.42M -47,731 Closed
LI
222
LMCG Investments
Massachusetts
– -$1.04M -40,003 Closed
GACM
223
Green Arrow Capital Management
New York
– -$1.04M -40,000 Closed
IHM
224
Iguana Healthcare Management
New York
– -$845K -32,500 Closed
UOC
225
UBS O'Connor
Illinois
– -$806K -31,000 Closed
6 7 8
9
10

NPSP Hedge Fund Activity: Q4 2014 in Review

213 of the 3,750 institutional investors tracked by Wall St. Rank reported a position in NPS PHARMACEUTICALS INC (NPSP) for Q4 2014, worth a combined $3.63B — up 39% from $2.61B a quarter earlier.

Buyers outnumbered sellers: 45 funds opened new NPSP positions and 28 closed out — a net gain of 17 holders — while 68 added to existing stakes and 83 trimmed.

The largest buyer was First Trust Advisors, opening a new position worth an estimated $70.9M. The largest seller was Wells Fargo, cutting an estimated $29.9M.

  • 213 institutional investors held NPS PHARMACEUTICALS INC (NPSP) as of Q4 2014, up from 200 in Q3 2014.
  • Funds reported $3.63B of NPS PHARMACEUTICALS INC stock for Q4 2014, up 39% quarter-over-quarter.
  • 45 funds opened new NPS PHARMACEUTICALS INC positions in Q4 2014 and 28 closed out, a net change of +17 holders.
  • The largest NPS PHARMACEUTICALS INC buyer in Q4 2014 was First Trust Advisors, an estimated $70.9M added.
  • The largest NPS PHARMACEUTICALS INC seller in Q4 2014 was Wells Fargo, an estimated $29.9M sold.

Based on aggregated 13F filings for Q4 2014.